Europe's largest commercial laboratory building under development in London

Kadans Science Partner (Kadans) and Canary Wharf Group (CWG) have entered into a joint venture collaboration to develop a new 70,000-square-foot life sciences-focused wet lab building in Canary Wharf, London. The construction of the asset is the first phase of the development of a world-leading life sciences center in the 3.3-acre North Quay area.

The two market leaders complement each other in this new form of cooperation. CWG's construction, development and spatial experience is additionally complemented by the expertise of Kadans; a European leader in the development and management of life sciences buildings and ecosystems.

The building, to be completed in 2026, will be the largest commercial laboratory building for life sciences in Europe with an area of 70,000 square meters and 22 floors. The building will serve primarily as a laboratory, with laboratory space possible on every floor thanks to complete flexibility.

Designed by KPF, the building is being developed to the highest standards of sustainability and technology. Kadans brings its extensive experience in developing multi-tenant lab and office buildings with vibrant communities.

Canary Wharf, London's major financial center, is one of the best connected locations in London and is served by the transportation network's three newest lines: DLR, Jubilee Line and, starting later this year, the Elizabeth Line. The Elizabeth Line provides a direct connection to London Heathrow Airport within 38 minutes. With London City Airport about 15 minutes away, the new plan becomes a crucial international hub for life science companies.

"Canary Wharf Group has been developing a vision for healthcare and life sciences since 2019. We are proud to work with an exceptional partner like Kadans, which is a European leader in the development and management of life sciences buildings and ecosystems," said Shobi Khan, CEO Canary Wharf Group. "Together we are realizing a world-class building that will provide state-of-the-art laboratory, office and innovation spaces for interesting and fast-growing companies in the health and life sciences sector."

Michel Leemhuis, CEO of Kadans Science Partner, adds: "Kadans wants to contribute to the innovative power of the life sciences sector by developing state-of-the-art lab buildings while also providing support and an international community. The collaboration with Canary Wharf Group, which fully supports our long-term partner AXA IM Alts, offers us a unique opportunity. Not only to develop a significant and sustainable new lab building, which will be the largest in Europe, but also to be the catalyst for a new, world-leading life sciences cluster and ecosystem in the British capital."

Cushman & Wakefield advised CWG; JLL advised Kadans on the joint venture.